Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic


      Surveillance of oral epithelial dysplasia results in a number of newly diagnosed cases of oral squamous cell carcinoma (SCC). The clinical stage of oral SCC at diagnosis influences the magnitude of treatment required and the prognosis. We aimed to document the stage, treatment, and outcome of oral SCC that arose in patients who were being monitored for oral epithelial dysplasia in a dedicated multidisciplinary clinic. Those with histologically diagnosed lesions were enrolled on an ethically approved protocol and molecular biomarker study. Details of clinical and pathological TNM, operation, radiotherapy, recurrence, second primary tumour, and prognosis, were recorded in patients whose lesions underwent malignant transformation. Of the 91 patients reviewed (median follow-up 48 months, IQR 18-96), 23 (25%) had malignant transformation. All were presented to the multidisciplinary team with stage 1 disease (cT1N0M0). Of these, 21 were initially treated by wide local excision, 2 required resection of tumour and reconstruction, and 2 required adjuvant radiotherapy. At follow-up 3 had local recurrence, one had regional recurrence, one had metachronous lung cancer, and 5 had second primary oral SCC. There were further diagnoses of oral dysplasia in 5 during follow-up, and it is estimated that 76% of patients will have one or other event in 5 years. Disease-specific survival was 100% and overall survival was 96% (22/23). Median follow-up after diagnosis of oral SCC was 24 months (IQR 11-58). Specialist monitoring of oral epithelial dysplasia by a multidisciplinary team allows oral SCC to be detected at an early stage, and enables largely curative treatment with simple and usually minor surgical intervention. The high incidence of second primary oral SCC in high-risk patients with oral epithelial dysplasia further supports intensive targeted surveillance in this group.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rogers S.N.
        • Brown J.S.
        • Woolgar J.A.
        • et al.
        Survival following primary surgery for oral cancer.
        Oral Oncol. 2009; 45: 201-211
        • Peacock Z.S.
        • Pogrel M.A.
        • Schmidt B.L.
        Exploring the reasons for delay in treatment of oral cancer.
        J Am Dent Assoc. 2008; 139: 1346-1352
        • Gómez I.
        • Warnakulasuriya S.
        • Varela-Centelles P.I.
        • et al.
        Is early diagnosis of oral cancer a feasible objective? Who is to blame for diagnostic delay?.
        Oral Dis. 2010; 16: 333-342
        • Ganly I.
        • Patel S.
        • Shah J.
        Early stage squamous cell cancer of the oral tongue – clinicopathologic features affecting outcome.
        Cancer. 2012; 118: 101-111
        • Brocklehurst P.
        • Kujan O.
        • Glenny A.M.
        • et al.
        Screening programmes for the early detection and prevention of oral cancer.
        Cochrane Database Syst Rev. 2010; : CD004150
        • Speight P.M.
        • Palmer S.
        • Moles D.R.
        • et al.
        The cost-effectiveness of screening for oral cancer in primary care.
        Health Technol Assess. 2006; 10: 1-144
        • Hall G.L.
        • Shaw R.J.
        • Field E.A.
        • et al.
        p16 Promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia.
        Cancer Epidemiol Biomarkers Prev. 2008; 17: 2174-2179
        • Ho M.W.
        • Risk J.M.
        • Woolgar J.A.
        • et al.
        The clinical determinants of malignant transformation in oral epithelial dysplasia.
        Oral Oncol. 2012; 48: 969-976
        • Aksu G.
        • Karadeniz A.
        • Saynak M.
        • et al.
        Treatment results and prognostic factors in oral tongue cancer: analysis of 80 patients.
        Int J Oral Maxillofac Surg. 2006; 35: 506-513
        • Koo B.S.
        • Lim Y.C.
        • Lee J.S.
        • et al.
        Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity.
        Oral Oncol. 2006; 42: 789-794
        • Morris L.G.
        • Sikora A.G.
        • Patel S.G.
        • et al.
        Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.
        J Clin Oncol. 2011; 29: 739-746
        • Rogers S.N.
        • Scott J.
        • Chakrabati A.
        • et al.
        The patients’ account of outcome following primary surgery for oral and oropharyngeal cancer using a ‘quality of life’ questionnaire.
        Eur J Cancer Care. 2008; 17 (English Language Edition): 182-188
        • Rogers S.N.
        • Lowe D.
        • Yueh B.
        • et al.
        The physical function and social-emotional function subscales of the University of Washington Quality of Life Questionnaire.
        Arch Otolaryngol Head Neck Surg. 2010; 136: 352-357